CRDF CARDIFF ONCOLOGY INC
2026Q1 · CUSIP 14147L108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
114
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
60
Δ whales
+5
Inst. holding value
$40M
New positions
22
Closed positions
18
Price momentum (1Q)
—
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q4 | Top 15% | -31.4% | -45.8% |
| 2024Q2 | Top 19% | — | — |
| 2024Q1 | Top 14% | — | — |
| 2021Q2 | Top 17% | +1.1% | -44.1% |
| 2020Q3 | Top 5% | -30.5% | -50.2% |
Options Sentiment
Put holders
1
QoQ: -1
Call holders
2
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.67
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-10.6%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)